Terminated PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT04933968

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Phase 1/2, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ALVR106 in Addition to Standard of Care for the Treatment of High-Risk Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Sponsor: AlloVir

Conditions Human Metapneumovirus (hMPV) Infection Influenza Infection Parainfluenza (PIV) Infection Respiratory Syncytial Viral (RSV) Infection Respiratory Tract Viral Infections

Interventions ALVR106 Placebo

Updated 5 times since 2021 Last updated: Jun 4, 2024 Started: Mar 21, 2022 Primary completion: Jan 31, 2024 Completion: Jan 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Strategic sponsor decision

Other terminated trials from AlloVir

See all terminations from AlloVir

This PHASE1/PHASE2 trial investigates Human Metapneumovirus (hMPV) Infection and Influenza Infection and is currently terminated or withdrawn. AlloVir leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Mar 2024 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2

Status: Recruiting → Terminated
May 2022 — Mar 2024 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2021 — May 2022 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AlloVir

Data source: AlloVir

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Boston, United States , Buffalo, United States , Chapel Hill, United States , Charleston, United States , Cleveland, United States , Duarte, United States , Durham, United States , Gainesville, United States , Houston, United States and 9 more locations